Cholethorax following Percutaneous Transhepatic Biliary Drainage

por Turkington, Richard C, Leggett, Julian J, Hurwitz, Jane, Eatock, Martin M
Publicado 2007

Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review

por O’Connor, Dominic, Brown, Malcolm, Eatock, Martin, Turkington, Richard C., Prue, Gillian
Publicado 2021

A DNA-damage immune response assay combined with PET biomarkers predicts response to neo-adjuvant chemotherapy and survival in oesophageal adenocarcinoma

por Foley, Kieran G., Lavery, Anita, Napier, Eoin, Campbell, David, Eatock, Martin M., Kennedy, Richard D., Bradley, Kevin M., Turkington, Richard C.
Publicado 2021

Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series

por Brown, Malcolm, O’Connor, Dominic, Turkington, Richard, Eatock, Martin, Vince, Rebecca, Hulme, Claire, Bowdery, Roy, Robinson, Rebecca, Wadsley, Jonathan, Maraveyas, Anthony, Prue, Gillian
Publicado 2023

Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma

por Propper, David, Jones, Keith, Anthoney, D. Alan, Mansoor, Wasat, Ford, Daniel, Eatock, Martin, Agarwal, Roshan, Inatani, Michiyasu, Saito, Tomohisa, Abe, Masaichi, Evans, T. R. Jeffry
Publicado 2016

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and cape...

por Thomas, Anne, Virdee, Pradeep S., Eatock, Martin, Lord, Simon R., Falk, Stephen, Anthoney, D. Alan, Turkington, Richard C., Goff, Matthew, Elhussein, Leena, Collins, Linda, Love, Sharon, Moschandreas, Joanna, Middleton, Mark R.
Publicado 2020

Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position

por Jones, Christopher M., Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek, Holyoake, Daniel, Hunt, Arabella, Jamieson, Nigel B., Palmer, Daniel H., Soonawalla, Zahir, Valle, Juan W., Hawkins, Maria A., Mukherjee, Somnath
Publicado 2020

Reply to Comment on “The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic”

por Jones, Christopher M., Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek, Holyoake, Daniel, Hunt, Arabella, Jamieson, Nigel B., Palmer, Daniel H., Soonawalla, Zahir, Valle, Juan W., Hawkins, Maria A., Mukherjee, Somnath
Publicado 2020

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma

por Blayney, Jaine K., Cairns, Lauren, Li, Gerald, McCabe, Niamh, Stevenson, Leanne, Peters, Christopher J., Reid, Nathan B., Spence, Veronica J., Chisambo, Chintapuza, McManus, Damian, James, Jacqueline, McQuaid, Stephen, Craig, Stephanie, Arthur, Kenneth, McArt, Darragh, Ong, Chin-Ann J., Lao-Sirieix, Pierre, Hamilton, Peter, Salto-Tellez, Manuel, Eatock, Martin, Coleman, Helen G., Fitzgerald, Rebecca C., Kennedy, Richard D., Turkington, Richard C.
Publicado 2018

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma

por Turkington, Richard C, Knight, Laura A, Blayney, Jaine K, Secrier, Maria, Douglas, Rosalie, Parkes, Eileen E, Sutton, Eilis K, Stevenson, Leanne, McManus, Damian, Halliday, Sophia, McCavigan, Andrena M, Logan, Gemma E, Walker, Steven M, Steele, Christopher J, Perner, Juliane, Bornschein, Jan, MacRae, Shona, Miremadi, Ahmad, McCarron, Eamon, McQuaid, Stephen, Arthur, Kenneth, James, Jacqueline A, Eatock, Martin M, O’Neill, Robert, Noble, Fergus, Underwood, Timothy J, Harkin, D Paul, Salto-Tellez, Manuel, Fitzgerald, Rebecca C, Kennedy, Richard D
Publicado 2019